Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study - Université de Bretagne Occidentale
Journal Articles Blood Year : 2017

Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study

Delphine Rea
  • Function : Author
Institut Universitaire d'Hématologie
Franck Nicolini
  • Function : Author
Service d’Hématologie [Centre Hospitalier Lyon Sud - HCL]
Michel Tulliez
  • Function : Author
François Guilhot
  • Function : Author
INSERM CIC 0802
Joëlle Guilhot
  • Function : Author
CIC Poitiers – Centre d'investigation clinique de Poitiers
Agnès Guerci-Bresler
  • Function : Author
  • PersonId : 908399
Service d'Hématologie Clinique [CHRU Nancy]
Martine Gardembas
  • Function : Author
Laboratoire d'hématologie [CHU Angers]
Valérie Coiteux
  • Function : Author
Institut Mondor de Recherche Biomédicale
Gaëlle Guillerm
  • Function : Author
Laboratoire d'hématologie
Laurence Legros
  • Function : Author
Institut de Biologie Valrose
Gabriel Etienne
Institut de pharmacologie et de biologie structurale
Jean-Michel Pignon
  • Function : Author
Bruno Villemagne
  • Function : Author
Hématologie clinique [CH La Roche-sur-Yon]
Martine Escoffre-Barbe
  • Function : Author
Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Pontchaillou]
Jean-Christophe Ianotto
  • Function : Author
CHRU Brest - Service d'Hématologie
Groupe d'Etude de la Thrombose de Bretagne Occidentale
CIC Brest
Aude Charbonnier
  • Function : Author
Hyacinthe Johnson-Ansah
  • Function : Author
Marie-Pierre Noel
  • Function : Author
Philippe Rousselot
Pathologie et virologie moléculaire
François Mahon
  • Function : Author

Domains

Life Sciences [q-bio] Human health and pathology Cancer Hematology

Ghislaine Calvez  : Connect in order to contact the contributor

https://hal.univ-brest.fr/hal-02050833

Submitted on : Wednesday, February 27, 2019-1:58:40 PM

Last modification on : Tuesday, July 16, 2024-3:14:04 PM

Consult the full text

Dates and versions

hal-02050833 , version 1 (27-02-2019)

Identifiers

Cite

Delphine Rea, Franck Nicolini, Michel Tulliez, François Guilhot, Joëlle Guilhot, et al.. Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study. Blood, 2017, 129 (7), pp.846-854. ⟨10.1182/blood-2016-09-742205⟩. ⟨hal-02050833⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-BREST UNIV-PARIS7 HCL CNRS UNIV-POITIERS CHLS IMRB GETBO UPEC UNAM USPC UNIV-COTEDAZUR SORBONNE-UNIVERSITE IBSAM IPBS UNIV-UT3 UT3-TOULOUSEINP
150 View
0 Download

Altmetric

Share

More